These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 17614825

  • 1. Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.
    Harmatz P, Grady RW, Dragsten P, Vichinsky E, Giardina P, Madden J, Jeng M, Miller B, Hanson G, Hedlund B.
    Br J Haematol; 2007 Aug; 138(3):374-81. PubMed ID: 17614825
    [Abstract] [Full Text] [Related]

  • 2. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
    Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP.
    Ann N Y Acad Sci; 2005 Aug; 1054():486-91. PubMed ID: 16339703
    [Abstract] [Full Text] [Related]

  • 3. Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.
    Wali YA, Taqi A, Deghaidi A.
    Pediatr Hematol Oncol; 2004 Aug; 21(5):453-60. PubMed ID: 15205089
    [Abstract] [Full Text] [Related]

  • 4. Urinary iron excretion induced by intravenous infusion of deferoxamine in beta-thalassemia homozygous patients.
    Boturao-Neto E, Marcopito LF, Zago MA.
    Braz J Med Biol Res; 2002 Nov; 35(11):1319-28. PubMed ID: 12426631
    [Abstract] [Full Text] [Related]

  • 5. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE, Hagiwara M, Thomas SK, Baladi JF, Phatak PD, Coates TD.
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [Abstract] [Full Text] [Related]

  • 6. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 Apr; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 7. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience.
    Abdelrazik N.
    Hematology; 2007 Dec; 12(6):577-85. PubMed ID: 17852442
    [Abstract] [Full Text] [Related]

  • 8. Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload.
    Borgna-Pignatti C, Franchini M, Gandini G, Vassanelli A, De Gironcoli M, Aprili G.
    Haematologica; 1998 Sep; 83(9):788-90. PubMed ID: 9825575
    [Abstract] [Full Text] [Related]

  • 9. Urinary iron excretion in young thalassemic patients receiving combined chelation treatment with deferoxamine and deferiprone.
    Christoforidis A, Zevgaridou E, Tsatra I, Perifanis V, Vlachaki E, Papassotiriou I, Apostolakou F, Athanassiou-Metaxa M.
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):598-601. PubMed ID: 17805032
    [Abstract] [Full Text] [Related]

  • 10. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P.
    Ann N Y Acad Sci; 2005 Sep; 1054():429-32. PubMed ID: 16339692
    [Abstract] [Full Text] [Related]

  • 11. High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration.
    Lombardo T, Ferro G, Frontini V, Percolla S.
    Am J Hematol; 1996 Jan; 51(1):90-2. PubMed ID: 8571945
    [Abstract] [Full Text] [Related]

  • 12. Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.
    Tamary H, Goshen J, Carmi D, Yaniv I, Kaplinsky C, Cohen IJ, Zaizov R.
    Isr J Med Sci; 1994 Aug; 30(8):658-64. PubMed ID: 8045754
    [Abstract] [Full Text] [Related]

  • 13. [Therapeuetic management of patients with thalassemia major].
    Thuret I.
    Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
    [Abstract] [Full Text] [Related]

  • 14. Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
    Cianciulli P, Forte L, Sorrentino F, Palombi M, Papa G, Marciani MG.
    Bone Marrow Transplant; 1993 May; 12 Suppl 1():5-8. PubMed ID: 8374563
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
    Rodríguez Galindo C, Ortega Aramburu JJ, Alonso JL, Albisu M, Casaldáliga J, Díaz de Heredia C, Olivé T, Bastida P.
    Med Clin (Barc); 1994 May 21; 102(19):721-4. PubMed ID: 8041200
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy.
    Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S.
    Blood; 1996 Jul 15; 88(2):705-13. PubMed ID: 8695819
    [Abstract] [Full Text] [Related]

  • 17. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
    Silliman CC, Peterson VM, Mellman DL, Dixon DJ, Hambidge KM, Lane PA.
    J Lab Clin Med; 1993 Jul 15; 122(1):48-54. PubMed ID: 8320490
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyethyl starch deferoxamine, a novel iron chelator, delays diabetes in BB rats.
    Roza AM, Slakey DP, Pieper GM, Van Ye TM, Moore-Hilton G, Komorowski RA, Johnson CP, Hedlund BE, Adams MB.
    J Lab Clin Med; 1994 Apr 15; 123(4):556-60. PubMed ID: 7511676
    [Abstract] [Full Text] [Related]

  • 19. First human studies with a high-molecular-weight iron chelator.
    Dragsten PR, Hallaway PE, Hanson GJ, Berger AE, Bernard B, Hedlund BE.
    J Lab Clin Med; 2000 Jan 15; 135(1):57-65. PubMed ID: 10638695
    [Abstract] [Full Text] [Related]

  • 20. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP, Kumar S, Choudhury P, Talukdar B, Puri RK.
    Indian Pediatr; 1993 Jun 15; 30(6):775-8. PubMed ID: 8132258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.